![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2023-10-25/polyplus-expands-lipidbrick-library-to-optimize-ln/?widget=listSection
https://www.reuters.com/business/healthcare-pharmaceuticals/sartorius-buy-polyplus-24-bln-euros-2023-03-31/
https://www.contractpharma.com/contents/view_breaking-news/2023-03-15/polyplus-introduces-lipidbrick-for-lnp-formulation/?widget=listSection
https://www.contractpharma.com/contents/view_breaking-news/2023-03-01/polyplus-strengthens-cgt-production-capabilities/?widget=listSection
https://www.contractpharma.com/contents/view_breaking-news/2022-12-14/polyplus-acquires-french-biotechnology-cdmo-bio-elpida/?widget=listSection
https://www.biospectrumasia.com/news/28/19654/polyplus-acquires-e-zyvec.html